Remdesivir killed my Dad

[Wingman68]

STORY AT-A-GLANCE

• The antiviral drug remdesivir, brand name Veklury, is approved for use against COVID-19 despite research showing it lacks effectiveness and can cause high rates of organ failure
• John Beaudoin is calling for a criminal investigation into remdesivir, citing data that it may have killed 100,000 people in the U.S.
• Beaudoin received all the death certificates in Massachusetts from 2015 to 2022, finding 1,840 excess deaths from acute renal failure from January 1, 2021, to November 30, 2022, which he believes may be due to remdesivir
• A study published in The Lancet found “no clinical benefit” from the use of remdesivir in hospitalized patients
• The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when remdesivir is used

The Fallout Caused by Remdesivir


When my Dad was hospitalized in late ‘20, he did not have covid. After a week in their care they said they tested him & it was positive. I questioned at the time about using the hydroxy combo or ivermectin, but got lectured on how that could be DANGEROUS! They were going with Remdesivir. He was gone in 3 days. The hospital was desolate at the time, they probably needed the government bonus incentives. Change my mind.

 

[Wingman68]

Trump is bad to the bone, they gave him a five day treatment & he survived. Foiled again! Notice in the USA article they pointed out that unlike hydroxy which Trump had touted…….Remdesivir was LESS CONTROVERSIAL. Wonder where they got that idea?? Oh yeah…..Fauci talking points. Fauci was financially enriched by the makers of Remdesivir.

President Trump given experimental COVID-19 drug remdesivir

 

[Wingman68]

On May 1, the NIH’s COVID-19 Treatment Guidelines panel members granted emergency use of remdesivir and stated HCQ could only be used in hospitals or in studies. Investigative journalist Sharyl Attkisson found 11 members of that panel had financial ties to Gilead. Two were on Gilead’s advisory board, others were paid consultants or received research support and honoraria. None of the members, however, had ties to HCQ, which is made by numerous generic manufacturers, and “is so cheap, analysts say even a spike in sales would not be a financial driver for the companies,” Ms. Attkisson reported.

Ms. Attkisson also found one of the authors of a small Veterans Administration trial that claimed HCQ caused increased deaths received a $247,000 grant from Gilead in 2018.
On May 1, the NIH’s COVID-19 Treatment Guidelines panel members granted emergency use of remdesivir and stated HCQ could only be used in hospitals or in studies. Investigative journalist Sharyl Attkisson found 11 members of that panel had financial ties to Gilead. Two were on Gilead’s advisory board, others were paid consultants or received research support and honoraria. None of the members, however, had ties to HCQ, which is made by numerous generic manufacturers, and “is so cheap, analysts say even a spike in sales would not be a financial driver for the companies,” Ms. Attkisson reported.

Ms. Attkisson also found one of the authors of a small Veterans Administration trial that claimed HCQ caused increased deaths received a $247,000 grant from Gilead in 2018.